Healthcare & Life Sciences
NeoTX
Israelneotx.com
NeoTX is a series c plus startup based in Israel.
Activeseries-c-plus
series-c-plus
Stage
2017
Founded
About NeoTX
NeoTX is a startup founded in 2017 based in Israel. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences.
NeoTX is a clinical-stage biopharmaceutical company developing targeted anticancer immunotherapies utilizing its proprietary Tumor-Targeted Superantigen (TTS) platform.
Explore NeoTX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.